MYCN and neuroblastoma: In this context, NB cell lines, which were selected to perform the biological assays, are characterized by a different status of MYCN-amplification that has been found to correlate with tumor aggressiveness, increased metastatic potential, poor prognosis and resistance to therapy [35, 36] remaining the most widely accepted predictive parameter of long-term, disease-free survival in the clinical setting [37].